This investment was made under a previous strategy. We disclose information on all our current investments, but narrative information on our pre-2012 investments, when we introduced a new strategy, may be limited.
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- South Asia
For funds, the countries listed here are those the fund has invested in so far.
- India, Sri Lanka
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.
- Communications and IT Services, Financial services, Health, Manufacturing
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- Actis LLP
- Start date
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- December 2007
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- United Kingdom
Investments made by this fund
|Investment name||Country||Region||Sector||Start date||Status|
SuperMax manufactures shaving products. It has a dominant market position in India in double-edged blades.
|India||South Asia||Manufacturing||February 2011||Active|
| AGS Transact Technologies|
AGS Transact Technologies offers ATM outsourced services and retail automation solutions.
|India||South Asia||Manufacturing||August 2012||Active|
| Symbiotec Pharmalab Limited|
A leading specialist producer of steroid- hormone active pharmaceutical ingredients (APIs). These active ingredients are used by Symbiotec’s 200+ customers, which include both large multinationals as well as generic pharma companies, to manufacture high quality medications, including treatments for inflammation, asthma, dermatology, immune functions, and infertility
|India||South Asia||Health||October 2013||Active|